Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -44.52M | -4069.47% | $ 1.09M |
3/31/2025 | $ -54.03M | -3667.96% | $ 1.47M |
12/31/2024 | $ -57.02M | -4125.69% | $ 1.38M |
9/30/2024 | $ -53.79M | -3370.55% | $ 1.6M |
6/30/2024 | $ -59.48M | -3615.81% | $ 1.65M |
3/31/2024 | $ -54.8M | -4102.1% | $ 1.34M |
12/31/2023 | $ -53.64M | -2776.24% | $ 1.93M |
9/30/2023 | $ -45.53M | -2184.64% | $ 2.08M |
6/30/2023 | $ -47.73M | -2533.28% | $ 1.88M |
3/31/2023 | $ -51.05M | -2363.29% | $ 2.16M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -27.87M ] / Revenues [ $ 1.69M ]
(=) OCF % [ -1653.89% ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.33% |
median | 12.67% |
std | 21.12% |